Medical Device Testing Malaysia
Medical Device Testing Malaysia is essential to ensure that medical devices meet strict safety, efficacy, and regulatory standards in Malaysia and across Southeast Asia. Adita Biosys, an India-based preclinical contract research organization (CRO) and GLP & ISO 17025-certified laboratory, offers advanced testing solutions to help manufacturers navigate the Malaysian Medical Device Authority (MDA) regulatory framework.
Our expert team provides ISO 10993, ASTM, US FDA, and MHLW-compliant testing, ensuring that your medical device is fully compliant with Malaysia’s Medical Device Act 2012, MDA requirements, and international standards
Furthermore, our services are designed to support manufacturers in CE Marking, EU MDR alignment, and global regulatory approvals, enabling faster market entry and reducing compliance risks.
Regulatory Requirements for Medical Devices in Malaysia
- Medical Device Authority (MDA) Registration: Mandatory for all medical devices marketed in Malaysia.
- Medical Device Act 2012 (Act 737): Establishes classification, registration, and regulatory obligations.
- ISO 13485 & ISO 10993 Compliance: Ensures quality management and biocompatibility standards.
- Risk Classification: Devices are classified into Class A, B, C, or D based on risk level.
- Good Laboratory Practice (GLP): Essential for preclinical and biological evaluation studies.
- International Compliance: Supports US FDA, EU MDR, CE Marking, and other international submissions.
Partnering with Adita Biosys ensures your device meets Malaysian regulatory requirements while maintaining global compliance and quality standards.
End-to-End Medical Device Testing Services
Biological Safety Evaluation
- Cytotoxicity Tests: MEM Elution, Agar Overlay, Direct Contact, MTT, XTT, NRU, Colony Formation
- Irritation Tests: Primary Skin Irritation, Intracutaneous Reactivity, Ocular Irritation, Mucosal/Special Irritation
- Skin Sensitization: Buehler Sensitization, Guinea Pig Maximisation, Local Lymph Node Assay (LLNA)
- Systemic Toxicity: Acute, Sub-acute, Sub-chronic, Chronic
- Hemocompatibility: Hemolysis, PTT, Complement Activation (SC5b-9), Platelet Aggregation, Leukocyte Activation, Hematology
- Pyrogenicity Tests: In vitro Bacterial Endotoxins, Material-mediated Rabbit Pyrogenicity Implantation Studies: Intramuscular, Subcutaneous, Bone
- Plastics & Material Testing: In vitro & in vivo biological reactivity tests
- Additional Studies: Carcinogenicity, Reproductive Toxicity, Teratogenicity
- Genotoxicity Testing: AMES Test, Mouse Lymphoma Assay, Micronucleus Test, Chromosomal Aberration
- Biological Evaluation & Risk Assessment: Biological Evaluation Plan, Toxicological Risk Assessment, Biological Evaluation Report
Why Choose Adita Biosys for Malaysia Market Testing?
- GLP & ISO 17025 Certified Laboratory: Ensures reliable testing under internationally recognized standards.
- Comprehensive End-to-End Services: From preclinical evaluation to regulatory submission support.
- E-E-A-T Expertise: Experienced professionals with in-depth knowledge of Malaysia and international regulations.
- Global Compliance Support: US FDA, EU MDR, CE Marking, ISO, ASTM, ASCA, AAMI, and pharmacopeia standards.
- Trusted by Clients Worldwide: Proven track record in supporting medical device approvals across markets.